GT Biopharma (GTBP) Price to Book (2010 - 2026)

GT Biopharma (GTBP) has reported Price to Book for 17 consecutive years, with 0.08 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Price to Book rose 134.04% year-over-year to 0.08 in Q1 2026; TTM through Mar 2026 was 0.08, a 134.04% increase from a year earlier, with the FY2025 full-year figure at 0.03, up 118.33% from the prior year.
• Price to Book was 0.08 for Q1 2026 at GT Biopharma, up from 0.03 in the prior quarter.
• Over five years, Price to Book peaked at 0.24 in Q2 2022 and troughed at 0.22 in Q1 2025.
• A 5-year average of 0.05 and a median of 0.05 in 2024 frame the typical range for Price to Book.
• Across the five-year window, Price to Book jumped 146.51% in 2024 and plunged 583.29% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 0.1 in 2022, then tumbled by 42.8% to 0.06 in 2023, then sank by 388.84% to 0.16 in 2024, then soared by 118.33% to 0.03 in 2025, then jumped by 153.21% to 0.08 in 2026.
• The last three Price to Book figures came in at 0.08 (Q1 2026), 0.03 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.